MEDIPOST Co., Ltd. (KOSDAQ:078160)

Verve Therapeutics Statistics

Total Valuation

MEDIPOST has a market cap or net worth of KRW 355.31 billion. The enterprise value is 350.29 billion.

Market Cap	355.31B
Enterprise Value	350.29B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDIPOST has 34.10 million shares outstanding. The number of shares has increased by 14.43% in one year.

Current Share Class	34.10M
Shares Outstanding	34.10M
Shares Change (YoY)	+14.43%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	0.57%
Float	20.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.95
PB Ratio	1.21
P/TBV Ratio	1.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.86
EV / Sales	4.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.80

Financial Position

The company has a current ratio of 5.41, with a Debt / Equity ratio of 0.04.

Current Ratio	5.41
Quick Ratio	4.17
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.26
Interest Coverage	-112.99

Financial Efficiency

Return on equity (ROE) is -22.65% and return on invested capital (ROIC) is -10.60%.

Return on Equity (ROE)	-22.65%
Return on Assets (ROA)	-8.39%
Return on Invested Capital (ROIC)	-10.60%
Return on Capital Employed (ROCE)	-14.98%
Revenue Per Employee	219.06M
Profits Per Employee	-219.71M
Employee Count	328
Asset Turnover	0.17
Inventory Turnover	1.83

Taxes

In the past 12 months, MEDIPOST has paid 24.97 million in taxes.

Income Tax	24.97M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +78.41% in the last 52 weeks. The beta is 0.50, so MEDIPOST's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+78.41%
50-Day Moving Average	11,084.00
200-Day Moving Average	9,674.50
Relative Strength Index (RSI)	40.95
Average Volume (20 Days)	50,269

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDIPOST had revenue of KRW 71.85 billion and -72.06 billion in losses. Loss per share was -2,113.41.

Revenue	71.85B
Gross Profit	44.44B
Operating Income	-56.45B
Pretax Income	-72.72B
Net Income	-72.06B
EBITDA	-50.45B
EBIT	-56.45B
Loss Per Share	-2,113.41

Balance Sheet

The company has 76.05 billion in cash and 11.76 billion in debt, giving a net cash position of 64.28 billion or 1,885.24 per share.

Cash & Cash Equivalents	76.05B
Total Debt	11.76B
Net Cash	64.28B
Net Cash Per Share	1,885.24
Equity (Book Value)	294.59B
Book Value Per Share	6,901.21
Working Capital	95.32B

Cash Flow

In the last 12 months, operating cash flow was -42.45 billion and capital expenditures -2.48 billion, giving a free cash flow of -44.92 billion.

Operating Cash Flow	-42.45B
Capital Expenditures	-2.48B
Free Cash Flow	-44.92B
FCF Per Share	-1,317.43

Margins

Gross margin is 61.85%, with operating and profit margins of -78.56% and -100.30%.

Gross Margin	61.85%
Operating Margin	-78.56%
Pretax Margin	-101.21%
Profit Margin	-100.30%
EBITDA Margin	-70.22%
EBIT Margin	-78.56%
FCF Margin	n/a

Dividends & Yields

MEDIPOST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.43%
Shareholder Yield	-14.43%
Earnings Yield	-20.28%
FCF Yield	-12.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 29, 2019. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2019
Split Type	Forward
Split Ratio	2

Scores

MEDIPOST has an Altman Z-Score of 1.14 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.14
Piotroski F-Score	3